Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis

Masanori Kuwabara, Yoshihiko Kakinuma, Motonori Ando, Rajesh G. Katare, Fumiyasu Yamasaki, Yoshinori Doi, Takayuki Sato

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background: Hypoxia-inducible factor (HIF)-1α regulates the transcription of lines of genes, including vascular endothelial growth factor (VEGF), a major gene responsible for angiogenesis. Several recent studies have demonstrated that a nonhypoxic pathway via nitric oxide (NO) is involved in the activation of HIF-1α. However, there is no direct evidence demonstrating the release of angiogenic factors by cardiomyocytes through the nonhypoxic induction pathway of HIF-1α in the heart. Therefore we assessed the effects of an NO donor, S-Nitroso-N-acetylpenicillamine (SNAP) on the induction of VEGF via HIF-1α under normoxia, using primary cultured rat cardiomyocytes (PRCMs). Methods and Results: PRCMs treated with acetylcholine (ACh) or SNAP exhibited a significant production of NO. SNAP activated the induction of HIF-1α protein expression in PRCMs during normoxia. Phosphatidylinositol 3-kinase (PI3K)-dependent Akt phosphorylation was induced by SNAP and was completely blocked by wortmannin, a PI3K inhibitor, and N G-nitro-L-arginine methyl ester (L-NAME), a NO synthase inhibitor. The SNAP treatment also increased VEGF protein expression in PRCMs. Furthermore, conditioned medium derived from SNAP-treated cardiomyocytes phosphorylated the VEGF type-2 receptor (Flk-1) of human umbilical vein endothelial cells (a fourfold increase compared to the control group, p <0.001, n = 5) and accelerated angiogenesis. Conclusion: Our results suggest that cardiomyocytes produce VEGF through a nonhypoxic HIF-1α induction pathway activated by NO, resulting in angiogenesis.

Original languageEnglish
Pages (from-to)95-101
Number of pages7
JournalJournal of Physiological Sciences
Volume56
Issue number1
DOIs
Publication statusPublished - Feb 2006
Externally publishedYes

Fingerprint

S-Nitroso-N-Acetylpenicillamine
Hypoxia-Inducible Factor 1
Cardiac Myocytes
Vascular Endothelial Growth Factor A
Nitric Oxide
Phosphatidylinositol 3-Kinase
NG-Nitroarginine Methyl Ester
Vascular Endothelial Growth Factor Receptor-2
Nitric Oxide Donors
Angiogenesis Inducing Agents
Human Umbilical Vein Endothelial Cells
Conditioned Culture Medium
Nitric Oxide Synthase
Genes
Acetylcholine
Proteins
Phosphorylation
Control Groups

Keywords

  • Angiogenesis
  • Cardiomyocyte
  • Flk-1
  • Nitric oxide
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Physiology

Cite this

Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis. / Kuwabara, Masanori; Kakinuma, Yoshihiko; Ando, Motonori; Katare, Rajesh G.; Yamasaki, Fumiyasu; Doi, Yoshinori; Sato, Takayuki.

In: Journal of Physiological Sciences, Vol. 56, No. 1, 02.2006, p. 95-101.

Research output: Contribution to journalArticle

Kuwabara, Masanori ; Kakinuma, Yoshihiko ; Ando, Motonori ; Katare, Rajesh G. ; Yamasaki, Fumiyasu ; Doi, Yoshinori ; Sato, Takayuki. / Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis. In: Journal of Physiological Sciences. 2006 ; Vol. 56, No. 1. pp. 95-101.
@article{e75f67a2b0b8426daf68ed25a49cc3aa,
title = "Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis",
abstract = "Background: Hypoxia-inducible factor (HIF)-1α regulates the transcription of lines of genes, including vascular endothelial growth factor (VEGF), a major gene responsible for angiogenesis. Several recent studies have demonstrated that a nonhypoxic pathway via nitric oxide (NO) is involved in the activation of HIF-1α. However, there is no direct evidence demonstrating the release of angiogenic factors by cardiomyocytes through the nonhypoxic induction pathway of HIF-1α in the heart. Therefore we assessed the effects of an NO donor, S-Nitroso-N-acetylpenicillamine (SNAP) on the induction of VEGF via HIF-1α under normoxia, using primary cultured rat cardiomyocytes (PRCMs). Methods and Results: PRCMs treated with acetylcholine (ACh) or SNAP exhibited a significant production of NO. SNAP activated the induction of HIF-1α protein expression in PRCMs during normoxia. Phosphatidylinositol 3-kinase (PI3K)-dependent Akt phosphorylation was induced by SNAP and was completely blocked by wortmannin, a PI3K inhibitor, and N G-nitro-L-arginine methyl ester (L-NAME), a NO synthase inhibitor. The SNAP treatment also increased VEGF protein expression in PRCMs. Furthermore, conditioned medium derived from SNAP-treated cardiomyocytes phosphorylated the VEGF type-2 receptor (Flk-1) of human umbilical vein endothelial cells (a fourfold increase compared to the control group, p <0.001, n = 5) and accelerated angiogenesis. Conclusion: Our results suggest that cardiomyocytes produce VEGF through a nonhypoxic HIF-1α induction pathway activated by NO, resulting in angiogenesis.",
keywords = "Angiogenesis, Cardiomyocyte, Flk-1, Nitric oxide, Vascular endothelial growth factor",
author = "Masanori Kuwabara and Yoshihiko Kakinuma and Motonori Ando and Katare, {Rajesh G.} and Fumiyasu Yamasaki and Yoshinori Doi and Takayuki Sato",
year = "2006",
month = "2",
doi = "10.2170/physiolsci.RP002305",
language = "English",
volume = "56",
pages = "95--101",
journal = "Journal of Physiological Sciences",
issn = "1880-6546",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis

AU - Kuwabara, Masanori

AU - Kakinuma, Yoshihiko

AU - Ando, Motonori

AU - Katare, Rajesh G.

AU - Yamasaki, Fumiyasu

AU - Doi, Yoshinori

AU - Sato, Takayuki

PY - 2006/2

Y1 - 2006/2

N2 - Background: Hypoxia-inducible factor (HIF)-1α regulates the transcription of lines of genes, including vascular endothelial growth factor (VEGF), a major gene responsible for angiogenesis. Several recent studies have demonstrated that a nonhypoxic pathway via nitric oxide (NO) is involved in the activation of HIF-1α. However, there is no direct evidence demonstrating the release of angiogenic factors by cardiomyocytes through the nonhypoxic induction pathway of HIF-1α in the heart. Therefore we assessed the effects of an NO donor, S-Nitroso-N-acetylpenicillamine (SNAP) on the induction of VEGF via HIF-1α under normoxia, using primary cultured rat cardiomyocytes (PRCMs). Methods and Results: PRCMs treated with acetylcholine (ACh) or SNAP exhibited a significant production of NO. SNAP activated the induction of HIF-1α protein expression in PRCMs during normoxia. Phosphatidylinositol 3-kinase (PI3K)-dependent Akt phosphorylation was induced by SNAP and was completely blocked by wortmannin, a PI3K inhibitor, and N G-nitro-L-arginine methyl ester (L-NAME), a NO synthase inhibitor. The SNAP treatment also increased VEGF protein expression in PRCMs. Furthermore, conditioned medium derived from SNAP-treated cardiomyocytes phosphorylated the VEGF type-2 receptor (Flk-1) of human umbilical vein endothelial cells (a fourfold increase compared to the control group, p <0.001, n = 5) and accelerated angiogenesis. Conclusion: Our results suggest that cardiomyocytes produce VEGF through a nonhypoxic HIF-1α induction pathway activated by NO, resulting in angiogenesis.

AB - Background: Hypoxia-inducible factor (HIF)-1α regulates the transcription of lines of genes, including vascular endothelial growth factor (VEGF), a major gene responsible for angiogenesis. Several recent studies have demonstrated that a nonhypoxic pathway via nitric oxide (NO) is involved in the activation of HIF-1α. However, there is no direct evidence demonstrating the release of angiogenic factors by cardiomyocytes through the nonhypoxic induction pathway of HIF-1α in the heart. Therefore we assessed the effects of an NO donor, S-Nitroso-N-acetylpenicillamine (SNAP) on the induction of VEGF via HIF-1α under normoxia, using primary cultured rat cardiomyocytes (PRCMs). Methods and Results: PRCMs treated with acetylcholine (ACh) or SNAP exhibited a significant production of NO. SNAP activated the induction of HIF-1α protein expression in PRCMs during normoxia. Phosphatidylinositol 3-kinase (PI3K)-dependent Akt phosphorylation was induced by SNAP and was completely blocked by wortmannin, a PI3K inhibitor, and N G-nitro-L-arginine methyl ester (L-NAME), a NO synthase inhibitor. The SNAP treatment also increased VEGF protein expression in PRCMs. Furthermore, conditioned medium derived from SNAP-treated cardiomyocytes phosphorylated the VEGF type-2 receptor (Flk-1) of human umbilical vein endothelial cells (a fourfold increase compared to the control group, p <0.001, n = 5) and accelerated angiogenesis. Conclusion: Our results suggest that cardiomyocytes produce VEGF through a nonhypoxic HIF-1α induction pathway activated by NO, resulting in angiogenesis.

KW - Angiogenesis

KW - Cardiomyocyte

KW - Flk-1

KW - Nitric oxide

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=33745592547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745592547&partnerID=8YFLogxK

U2 - 10.2170/physiolsci.RP002305

DO - 10.2170/physiolsci.RP002305

M3 - Article

C2 - 16779917

AN - SCOPUS:33745592547

VL - 56

SP - 95

EP - 101

JO - Journal of Physiological Sciences

JF - Journal of Physiological Sciences

SN - 1880-6546

IS - 1

ER -